Bone-site-specific responses to zoledronic acid.

about

Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials

P2860

Q58791940-4B5DD5F2-412A-41E1-B527-37131E4BEB9E

P2860

Bone-site-specific responses to zoledronic acid.

Item

http://www.wikidata.org/entity/Q46276699

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Bone-site-specific responses to zoledronic acid.

@en

Bone-site-specific responses to zoledronic acid.

@nl

type

Item

label

Bone-site-specific responses to zoledronic acid.

@en

Bone-site-specific responses to zoledronic acid.

@nl

prefLabel

Bone-site-specific responses to zoledronic acid.

@en

Bone-site-specific responses to zoledronic acid.

@nl

P1476

Bone-site-specific responses to zoledronic acid.

@en

P2093

Gap Renders

http://www.w3.org/2001/XMLSchema#string

Idc Jansen

http://www.w3.org/2001/XMLSchema#string

L F Bakker

http://www.w3.org/2001/XMLSchema#string

M A van Duin

http://www.w3.org/2001/XMLSchema#string

S A Kroon

http://www.w3.org/2001/XMLSchema#string

T J de Vries

http://www.w3.org/2001/XMLSchema#string

V Everts

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

Osteonecrosis of the jaw and the role of macrophages

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

Jaw and long bone marrows have a different osteoclastogenic potential

Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate.

Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs

Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo

Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.

Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats.

P304

126-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ODI.12587

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jenny A F Vermeer

P577

2016-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27706930

http://www.w3.org/2001/XMLSchema#string

Bone-site-specific responses to zoledronic acid.

about

P2860

P2860

Bone-site-specific responses to zoledronic acid.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698